Does this mean the disease progression has been halted?
There were no significant differences in ALSFRS-R scores between pre-dose and end of treatment for all 12
patients (p=0.78), Cohort 1 (p=0.41), and Cohort 2 (p=0.88) suggesting that treatment with monepantel over 8 –
12 months slowed the rate of disease progression.
- Forums
- ASX - By Stock
- PAA
- Ann: Positive Phase 1 MEND Study Top-Line Results
Ann: Positive Phase 1 MEND Study Top-Line Results, page-5
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.5¢ |
Change
-0.005(2.94%) |
Mkt cap ! $80.25M |
Open | High | Low | Value | Volume |
17.0¢ | 17.0¢ | 16.5¢ | $70.28K | 418.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 217323 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 43978 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 217323 | 0.165 |
8 | 342325 | 0.160 |
9 | 701734 | 0.155 |
5 | 147993 | 0.150 |
3 | 73142 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 43978 | 1 |
0.175 | 2114 | 1 |
0.180 | 166580 | 4 |
0.185 | 175000 | 5 |
0.190 | 700126 | 7 |
Last trade - 16.10pm 18/09/2024 (20 minute delay) ? |
Featured News
PAA (ASX) Chart |